Larvol Delta - BioPath-Holdings-Presents-Data-from-Ongoing-Phase-2-Combination-Study-of-Prexigebersen-for-Treatment-of-Acute-Myeloid-Leukemia-at-European-Hematology-Association-Congress

prexigebersen (BP1001) - Bio-Path

https://www.globenewswire.com/news-release/2024/06/14/2898892/0/en/Bio-Path-Holdings-Presents-Data-from-Ongoing-Phase-2-Combination-Study-of-Prexigebersen-for-Treatment-of-Acute-Myeloid-Leukemia-at-European-Hematology-Association-Congress.html

Jun 14, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next